ATE304020T1 - Parathyroidhormon-verwandthe peptidanaloge - Google Patents

Parathyroidhormon-verwandthe peptidanaloge

Info

Publication number
ATE304020T1
ATE304020T1 AT97935197T AT97935197T ATE304020T1 AT E304020 T1 ATE304020 T1 AT E304020T1 AT 97935197 T AT97935197 T AT 97935197T AT 97935197 T AT97935197 T AT 97935197T AT E304020 T1 ATE304020 T1 AT E304020T1
Authority
AT
Austria
Prior art keywords
parathyroid hormone
related peptide
peptide analogs
pth
hormone related
Prior art date
Application number
AT97935197T
Other languages
English (en)
Inventor
Thomas J Gardella
Harald Jueppner
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of ATE304020T1 publication Critical patent/ATE304020T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/635Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/20Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Spectrometry And Color Measurement (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT97935197T 1996-07-31 1997-07-30 Parathyroidhormon-verwandthe peptidanaloge ATE304020T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2547196P 1996-07-31 1996-07-31
PCT/US1997/013360 WO1998004591A1 (en) 1996-07-31 1997-07-30 Novel parathyroid hormone-related peptide analogs

Publications (1)

Publication Number Publication Date
ATE304020T1 true ATE304020T1 (de) 2005-09-15

Family

ID=21826255

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97935197T ATE304020T1 (de) 1996-07-31 1997-07-30 Parathyroidhormon-verwandthe peptidanaloge

Country Status (8)

Country Link
US (2) US6147186A (de)
EP (1) EP0917537B1 (de)
JP (2) JP4142743B2 (de)
AT (1) ATE304020T1 (de)
AU (1) AU3819497A (de)
DE (1) DE69734157T2 (de)
ES (1) ES2248853T3 (de)
WO (1) WO1998004591A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6147186A (en) * 1996-07-31 2000-11-14 The General Hospital Corporation Parathyroid hormone-related peptide analogs
EP1075491B1 (de) 1998-05-05 2008-04-16 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Pth2 rezeptor selektive verbindungen
WO2000023594A1 (en) * 1998-10-22 2000-04-27 The General Hospital Corporation BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP)
AU5877300A (en) * 1999-06-15 2001-01-02 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Pth2 and pth1 receptor ligands
AU7734800A (en) * 1999-09-29 2001-04-30 General Hospital Corporation, The Polypeptide derivatives of parathyroid hormone (pth)
US20050124537A1 (en) * 2000-04-27 2005-06-09 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US6756480B2 (en) 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
EP1439854B1 (de) * 2001-07-23 2016-12-14 The General Hospital Corporation Parathormon (pth)-analoga mit beschränkter konformation
JP2005525312A (ja) * 2002-01-10 2005-08-25 オステオトロフィン エルエルシー 骨同化物質を用いた骨疾患の治療方法
US7906480B2 (en) * 2002-05-23 2011-03-15 Michael Holick Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy
AU2002951372A0 (en) * 2002-09-13 2002-09-26 St Vincent's Institute Of Medical Research Parathyroid hormone-like polypeptides
US7795220B2 (en) * 2003-03-19 2010-09-14 The General Hospital Corporation Conformationally constrained parathyroid hormones with alpha-helix stabilizers
WO2005009358A2 (en) * 2003-07-17 2005-02-03 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
EP1744683B1 (de) 2004-05-13 2016-03-16 Alza Corporation Gerät und verfahren für die transdermale abgabe von parathyroidhormon-mitteln
US20060068426A1 (en) * 2004-08-20 2006-03-30 Tam James P Cyclic peptides and antibodies thereof
WO2007133580A2 (en) * 2006-05-09 2007-11-22 Zelos Therapeutics, Inc. Use of pth (1-31) and optionally g-csf for hematopoietic stimulation
EP2054077A4 (de) * 2006-08-04 2010-10-13 Gen Hospital Corp Polypeptidderivate des parathyroidhormons (pth)
EP1961765A1 (de) * 2006-12-08 2008-08-27 Zealand Pharma A/S Verkürzte PTH-Peptide mit zyklischer Konformation
ES2583002T3 (es) 2007-04-09 2016-09-16 The Board Of Trustees Of The University Of Arkansas Proteínas de fusión de un dominio de enlazamiento a colágeno y hormona paratiroidea
CA3017668C (en) * 2007-08-01 2021-11-09 The General Hospital Corporation Screening methods using g-protein coupled receptors and related compositions
CN102448482A (zh) 2009-03-27 2012-05-09 范安德尔研究所 甲状旁腺素肽和甲状旁腺素相关蛋白肽及使用方法
PL2459208T3 (pl) 2009-07-29 2017-05-31 Kai Pharmaceuticals, Inc. Środki lecznicze zmniejszające poziom parathormonu
MX358161B (es) 2010-05-13 2018-08-06 The General Hospital Corp Star Analogos de hormona paratiroidea y usos para los mismos.
CN104168955A (zh) * 2011-11-10 2014-11-26 凯伊药品公司 拟钙剂及其使用方法
WO2013120060A1 (en) 2012-02-09 2013-08-15 The Board Of Trustees Of The University Of Arkansas Delivery of therapeutic agents by a collagen binding protein
US9579273B2 (en) 2011-12-14 2017-02-28 The Kitasato Institute Delivery of therapeutic agents by a collagen binding protein
MX368575B (es) 2013-03-15 2019-10-08 Fundacio Inst De Recerca Biomedica Irb Barcelona Métodos in vitro para el pronóstico, diagnóstico y diseño de una terapia personalizada de metástasis de cáncer de mama.
WO2018148573A1 (en) 2017-02-10 2018-08-16 The Board Of Trustees Of The University Of Arkansas Collagen-binding agent compositions and methods of using the same
JP2021516222A (ja) 2018-03-16 2021-07-01 ザ ジェネラル ホスピタル コーポレイション 副甲状腺ホルモンポリペプチドコンジュゲートおよびその使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0341962B1 (de) * 1988-05-09 1995-03-15 Merck & Co. Inc. Hemmer vom flüssigen kalziumerhöhenden Faktor
ATE287898T1 (de) * 1991-04-05 2005-02-15 Gen Hospital Corp Parathyroid-hormon-rezeptor und seine kodierende dna
US5821225A (en) 1992-07-14 1998-10-13 Syntex (U.S.A.) Inc. Method for the treatment of corticosteroid induced osteopenia comprising administration of modified PTH or PTHrp
US5589452A (en) 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
US5977070A (en) 1992-07-14 1999-11-02 Piazza; Christin Teresa Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
CN1070500C (zh) * 1993-07-13 2001-09-05 森德克斯(美国)股份有限公司 甲状旁腺激素类似物和甲状旁腺激素相关肽:合成和治疗骨质疏松症的用途
CO4410206A1 (es) * 1994-07-28 1997-01-09 Sandoz Ag DERIVADOS DE PTH o PTHrP, SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LAS COMPRENDEN
US6147186A (en) * 1996-07-31 2000-11-14 The General Hospital Corporation Parathyroid hormone-related peptide analogs

Also Published As

Publication number Publication date
EP0917537A1 (de) 1999-05-26
JP2001500476A (ja) 2001-01-16
JP2008074868A (ja) 2008-04-03
WO1998004591A1 (en) 1998-02-05
US6362163B1 (en) 2002-03-26
US6147186A (en) 2000-11-14
AU3819497A (en) 1998-02-20
EP0917537B1 (de) 2005-09-07
JP4142743B2 (ja) 2008-09-03
DE69734157D1 (en) 2005-10-13
DE69734157T2 (de) 2006-07-13
ES2248853T3 (es) 2006-03-16

Similar Documents

Publication Publication Date Title
ATE304020T1 (de) Parathyroidhormon-verwandthe peptidanaloge
HUP9904596A1 (hu) Mellékpajzsmirigy-hormon analógok
HUP9901718A2 (hu) Parathyroid hormon analógok
ATE384743T1 (de) Aminoterminal modifizierte parathyroidhormon (pth) analoge
IL163066A (en) Ligands for the zcytor17 receptor
EP0748817A3 (de) Parathyroidhormonderivaten und deren Verwendung
ES2091317T3 (es) Metodo para la deteccion cuantitativa de tirotropina (tsh) o de autoanticuerpos de receptores de antitirotropina (anti-tshr), utilizando un polipeptido receptor de tirotropina recombinante, y kit para realizar dicho metodo.
WO2001023521A3 (en) Polypeptide derivatives of parathyroid hormone (PTH)
NO873351L (no) Haarrensemiddelblanding og anvendelse av denne.
MX9705719A (es) Metodo para la sintesis de analogos de la hormona paratiroidea y del peptido relacionado con la hormona paratioridea.
EP0475394A3 (en) Rat c-type natriuretic peptide cdna and precursor protein
NO971621D0 (no) Keratinocyttvekstfaktoranaloger
ES2095255T3 (es) Analogos de sustitucion de peptidos magainina.
DK0630365T3 (da) Fremgangsmåde til fremstilling af beta-phenylisoserin og analoge deraf
ATE111090T1 (de) Verfahren zur stereoselektiven herstellung von 8- g(a),12-oxido-13,14,15,16-tetranorlabdan.
DE60040678D1 (en) Parathyroid hormon (pth) polypeptidderivate
ES8207511A1 (es) Un procedimiento para la preparacion de nuevos peptidos.
UA41300C2 (uk) Аналоги гормонів-антагоністів lhrh і спосіб їх отримання
ES2114220T3 (es) Peptido inhibidor de la fosfolipasa c.
PT87239A (pt) Process for the preparation of peptides
JPS5434734A (en) Priority deciding circuit
TH1762EX (th) เพพไทด์สังเคราะห์ที่แสดงฤทธิ์ปลดปล่อยฮอร์โมนช่วยการเติบโตของพิทูอิทารี
NO950114L (no) Amylin-antagonister og agonister

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties